Evofem announces Emirati health care filed application with UAE MOHAP

Evofem (EVFM) Biosciences announced that private Emirati health care company Pharma 1 Drug Store LLC has filed an application with the United Arab Emirates, UAE, Ministry of Health and Prevention, MOHAP, seeking approval to commercialize PHEXXI Evofem’s FDA-approved hormone-free contraceptive, in the UAE. “With the submission to MOHAP now complete, we are developing our commercial strategy for PHEXXI in the UAE and look forward to launching this important product as quickly as possible following approval,” said Abdulwahab Atfah, CEO of Pharma 1 Drug Store. “Market research indicates a growing demand for hormone-free, on demand contraception in the UAE and the surrounding region. We expect PHEXXI will be extremely well received among OB/GYNs and the women they serve.”